FamullaSHövelmannUFischerA. Lipohypertrophy leads to blunted, more variable insulin absorption and action in patients with type 1 diabetes. Diabetes. 2015;6 (suppl).
2.
BlancoMHernándezMTStraussKWAmayaM.Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445-453.
3.
Forum for Injection Technique and Therapy Expert Recommendations (FITTER), October23-25, 2015; Rome, Italy. www.fitter4diabetes.com.
